SU457217A3 - Способ получени несимметричных эфиров 1,4-дигидропиридинкарбоновой кислоты - Google Patents

Способ получени несимметричных эфиров 1,4-дигидропиридинкарбоновой кислоты

Info

Publication number
SU457217A3
SU457217A3 SU1888525A SU1888525A SU457217A3 SU 457217 A3 SU457217 A3 SU 457217A3 SU 1888525 A SU1888525 A SU 1888525A SU 1888525 A SU1888525 A SU 1888525A SU 457217 A3 SU457217 A3 SU 457217A3
Authority
SU
USSR - Soviet Union
Prior art keywords
ester
acid
ethyl
acetic acid
esters
Prior art date
Application number
SU1888525A
Other languages
English (en)
Russian (ru)
Inventor
Мейер Хорст
Боссерт Фридрих
Фатер Вульф
Штепель Курт
Original Assignee
Байер Аг (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Аг (Фирма) filed Critical Байер Аг (Фирма)
Application granted granted Critical
Publication of SU457217A3 publication Critical patent/SU457217A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SU1888525A 1972-03-06 1973-02-28 Способ получени несимметричных эфиров 1,4-дигидропиридинкарбоновой кислоты SU457217A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210672A DE2210672C3 (de) 1972-03-06 1972-03-06 N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
SU457217A3 true SU457217A3 (ru) 1975-01-15

Family

ID=5838025

Family Applications (6)

Application Number Title Priority Date Filing Date
SU1888525A SU457217A3 (ru) 1972-03-06 1973-02-28 Способ получени несимметричных эфиров 1,4-дигидропиридинкарбоновой кислоты
SU1888150A SU470958A3 (ru) 1972-03-06 1973-02-28 Способ получени производных 2-амино-1,4-дигидропиридина
SU1888534A SU466656A3 (ru) 1972-03-06 1973-02-28 Способ получени 2,6-диаминодигидропиридинов
SU1888153A SU468416A3 (ru) 1972-03-06 1973-02-28 Способ получени эфиров 2-амино-4,5дигидропиридин-3,5-дикарбоновой кислоты
SU1888529A SU451241A3 (ru) 1972-03-06 1973-02-28 Способ получени 2,6-диамино-дигидропиридинов
SU1888533A SU464111A3 (ru) 1972-03-06 1973-02-28 Способ получени несимметричных эфиров 1,4-дигидропиридинкарбоновой кислоты

Family Applications After (5)

Application Number Title Priority Date Filing Date
SU1888150A SU470958A3 (ru) 1972-03-06 1973-02-28 Способ получени производных 2-амино-1,4-дигидропиридина
SU1888534A SU466656A3 (ru) 1972-03-06 1973-02-28 Способ получени 2,6-диаминодигидропиридинов
SU1888153A SU468416A3 (ru) 1972-03-06 1973-02-28 Способ получени эфиров 2-амино-4,5дигидропиридин-3,5-дикарбоновой кислоты
SU1888529A SU451241A3 (ru) 1972-03-06 1973-02-28 Способ получени 2,6-диамино-дигидропиридинов
SU1888533A SU464111A3 (ru) 1972-03-06 1973-02-28 Способ получени несимметричных эфиров 1,4-дигидропиридинкарбоновой кислоты

Country Status (25)

Country Link
US (1) US3883540A (cg-RX-API-DMAC7.html)
JP (1) JPS5626657B2 (cg-RX-API-DMAC7.html)
KR (1) KR780000010B1 (cg-RX-API-DMAC7.html)
AT (1) AT324335B (cg-RX-API-DMAC7.html)
AU (1) AU468879B2 (cg-RX-API-DMAC7.html)
BE (1) BE796274A (cg-RX-API-DMAC7.html)
BG (2) BG22389A3 (cg-RX-API-DMAC7.html)
CA (1) CA1045138A (cg-RX-API-DMAC7.html)
CH (2) CH579049A5 (cg-RX-API-DMAC7.html)
CS (2) CS173649B2 (cg-RX-API-DMAC7.html)
DD (1) DD107456A5 (cg-RX-API-DMAC7.html)
DE (1) DE2210672C3 (cg-RX-API-DMAC7.html)
DK (1) DK136900C (cg-RX-API-DMAC7.html)
ES (2) ES412319A1 (cg-RX-API-DMAC7.html)
FR (1) FR2183674B1 (cg-RX-API-DMAC7.html)
GB (1) GB1384031A (cg-RX-API-DMAC7.html)
HU (1) HU164867B (cg-RX-API-DMAC7.html)
IE (1) IE37366B1 (cg-RX-API-DMAC7.html)
IL (1) IL41668A (cg-RX-API-DMAC7.html)
LU (1) LU67146A1 (cg-RX-API-DMAC7.html)
NL (1) NL7303135A (cg-RX-API-DMAC7.html)
PL (2) PL92117B1 (cg-RX-API-DMAC7.html)
RO (2) RO63067A (cg-RX-API-DMAC7.html)
SU (6) SU457217A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA731500B (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
US3974278A (en) * 1973-07-12 1976-08-10 Bayer Aktiengesellschaft 1,4-Dihydropyridine esters
CH607848A5 (cg-RX-API-DMAC7.html) * 1974-06-04 1978-11-30 Bayer Ag
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
US4466972A (en) * 1977-06-20 1984-08-21 Sandoz Ltd. Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
SU798099A1 (ru) * 1978-03-06 1981-01-23 Ордена Трудового Красного Знамениинститут Органического Синтезаан Латвийской Ccp 1-Бензил-2,6-диметил-4-о-или-M-НиТРОфЕНил-3,5-диэТОКСиКАРбОНил- 1,4-дигидРОпиРидиНы, пРО Вл ющиЕКОРОНАРОдилАТиРующую АКТиВНОСТь
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
IL68604A0 (en) * 1982-05-21 1983-09-30 Haessle Ab Processes for preparing therapeutically active dihydropyridines and intermediates for the processes
DE3312283A1 (de) * 1983-04-05 1984-10-18 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von unsymmetrischen 1,4-dihydropyridincarbonsaeureestern
US5237089A (en) * 1986-02-07 1993-08-17 Basf Aktiengesellschaft Nitro or amino substituted phenylalkyl or phenylalkenyl carboxylic acid derivatives
DE3724399A1 (de) * 1987-07-23 1989-02-02 Basf Ag Phenylalkenylcarbonsaeuren und deren ester
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
EP0330470A3 (en) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. 1,4-dihydropyridine derivatives useful against tumour cells
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
DE4133257A1 (de) * 1991-10-08 1993-04-15 Bayer Ag N-methyl-nimodipin, verfahren zu seiner herstellung und seine verwendung als zerebraltherapeutikum
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白(rap)-缀合物对肝病症的治疗
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
CN110075069A (zh) 2009-05-06 2019-08-02 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN110606822A (zh) * 2011-11-24 2019-12-24 里克特吉迪翁公司 具有hsp调节活性的1,4-二氢吡啶衍生物
JP7411994B2 (ja) 2020-03-19 2024-01-12 昌史 星野 腰枕および腰枕セット

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2359329A (en) * 1943-06-18 1944-10-03 Burroughs Wellcome Co Quinoline substituted dihydropyridines
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
JPS5626657B2 (cg-RX-API-DMAC7.html) 1981-06-19
LU67146A1 (cg-RX-API-DMAC7.html) 1973-05-22
CS173649B2 (cg-RX-API-DMAC7.html) 1977-02-28
DD107456A5 (cg-RX-API-DMAC7.html) 1974-08-05
US3883540A (en) 1975-05-13
IL41668A (en) 1977-02-28
AU5287673A (en) 1975-03-27
ZA731500B (en) 1973-11-28
BE796274A (fr) 1973-09-05
PL89257B1 (cg-RX-API-DMAC7.html) 1976-11-30
DE2210672B2 (de) 1979-07-12
SU468416A3 (ru) 1975-04-25
HU164867B (cg-RX-API-DMAC7.html) 1974-05-28
FR2183674B1 (cg-RX-API-DMAC7.html) 1976-10-22
SU451241A3 (ru) 1974-11-25
DE2210672C3 (de) 1980-03-20
FR2183674A1 (cg-RX-API-DMAC7.html) 1973-12-21
ES439487A1 (es) 1977-02-01
DK136900B (da) 1977-12-12
KR780000010B1 (en) 1978-03-04
CH579049A5 (cg-RX-API-DMAC7.html) 1976-08-31
IE37366L (en) 1973-09-06
JPS4899179A (cg-RX-API-DMAC7.html) 1973-12-15
SU470958A3 (ru) 1975-05-15
NL7303135A (cg-RX-API-DMAC7.html) 1973-09-10
SU464111A3 (ru) 1975-03-15
BG22389A3 (bg) 1977-02-20
RO62798A (fr) 1977-11-15
AU468879B2 (en) 1975-03-27
AT324335B (de) 1975-08-25
IE37366B1 (en) 1977-07-06
ES412319A1 (es) 1976-05-01
DE2210672A1 (de) 1973-09-20
IL41668A0 (en) 1973-05-31
BG20351A3 (bg) 1975-11-05
RO63067A (fr) 1978-05-15
CA1045138A (en) 1978-12-26
CH578530A5 (cg-RX-API-DMAC7.html) 1976-08-13
CS173624B2 (cg-RX-API-DMAC7.html) 1977-02-28
GB1384031A (en) 1975-02-19
DK136900C (da) 1978-05-22
PL92117B1 (cg-RX-API-DMAC7.html) 1977-03-31
SU466656A3 (ru) 1975-04-05

Similar Documents

Publication Publication Date Title
SU457217A3 (ru) Способ получени несимметричных эфиров 1,4-дигидропиридинкарбоновой кислоты
SU516352A3 (ru) Способ получени сложных эфиров 1,4-дигидропиридинкарбоновой кислоты или их солей
SU510997A3 (ru) Способ получени 1,4дигидропиридинов или их солей
SU932988A3 (ru) Способ получени оптически активных производных 1,4-дигидропиридинкарбоновой кислоты
SU906346A3 (ru) Фунгицидное средство
SU440837A1 (cg-RX-API-DMAC7.html)
JPS62277375A (ja) α−置換γ−ブチロラクトンの製法
SU496724A3 (ru) Способ получени аминоспиртов
US4772711A (en) Method for the preparation of 3-aminoacrylic acid esters
ES446690A1 (es) Procedimiento para la preparacion de nuevos acidos 3-(4-bi- fenilil)-butiricos, sus esteres y amidas.
US3646061A (en) Method of preparing n-alkoxalyl and n-formyl derivatives of alpha-amino acid esters
SU617007A3 (ru) Способ получени аминов или их солей
US4703119A (en) Intermediates of optically active 1,4-dihydropyridines
DE2406972C3 (de) Verfahren zur Herstellung von 5-Sulfamoylanthranilsäuren
JPS61134351A (ja) 4‐アシルオキシ‐3‐オキソ‐酪酸エステル類の製造方法
SU381669A1 (ru) Способ получения замещенных фенил- 7р?г-бутилпероксиамидофосфазоэтиленов
US2459111A (en) Pantoyltauramides and preparation of the same
SU1735283A1 (ru) Способ получени N-метилпирролидона
DK141621B (da) Fremgangsmåde til fremstilling af succinyloravsyrediestere.
KR900005698B1 (ko) α-옥시케톤의 디옥솔란 유도체의 제조방법
SU1313856A1 (ru) Способ получени производных цис- или транс-диаминодибензоилдибензо-18-краун-6
SU687070A1 (ru) Способ получени 2-амино-4(5н)кетопирролов
SU1164232A1 (ru) Способ получени 2-ацетиламинобензимидазола
SU1766254A3 (ru) Способ получени диметилового эфира 1,4-дигидро-2,6-диметил-4-/2-нитрофенил/-пиридин-3,5-дикарбоновой кислоты
SU455948A1 (ru) Способ получени замещенных гидразидов аренсульфонилоксаминовых кислот